Electromed, Inc.

AMEX:ELMD

Medical - Devices

Healthcare
$23.40 +1.16%

+$0.43 today

Market cap
$191.27M
Beta
0.52
P/E (TTM)
30.5
EPS (TTM)
$1.23
52W Low $17.73High $40.00

Volume 0.05M

Average 0.06M

ELMD Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

Electromed, Inc.AMEX: ELMD

Accounts Receivables · Q3 FY2026 · quarter ended Mar 2026

Accounts receivables growth accelerates

Q3 FY2026 accounts receivables of $1.93M (cash outflow) rose 142.4% year over year, ahead of the -683.9% change in trailing-twelve-month accounts receivables. Sequentially, it rose 29.5% from the prior quarter. Over 3 fiscal years it compounded at -25.1% a year.

Context

  • Accounts receivables amounted to 2.6% of revenue in FY2025, up 1.5 pp from a year earlier.
  • Accounts receivables increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +142.4% holds above the trailing-twelve-month pace of -683.9%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$1.93M+29.5% QoQ
Last fiscal yearJun 2025
-$1.64M-391.0% YoY
LTMMar 2026
-$3.56M-683.9% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+142.4%——
1 year-391.0%——
3-year CAGR-25.1%——
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
(1.64M) USD
Year-over-year change
-391.0%

Accounts Receivables vs competitors

How ELMD compares with its peers on the latest reported figures

  • ELMD's LTM Mar 2026 accounts receivables of $3.56M is the 3rd largest of the 6 companies compared; the peer median is $2.56M.
  • Its year-over-year change of -683.9% is the lowest of 6, against a peer median of +103.9%.
  • Accounts receivables amounts to 5.0% of revenue for ELMD, versus a peer median of 1.0%.
ELMD Competitors Peer median
Accounts Receivables for ELMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
RMDResMed Inc.LTM Jun 2026$156.35M +103.9%-3.1%2.8%
AHCOAdaptHealth Corp.LTM Apr 2026$25.35M +2637.1%—0.9%
ELMDElectromed, Inc.LTM Mar 2026$3.56M -683.9%-25.1%5.0%
TCMDTactile Systems Technology, Inc.LTM Mar 2026$3.42M -129.1%-78.6%1.0%
LUNGPulmonx CorporationLTM Mar 2026$3M +188.4%—3.4%
VMDViemed Healthcare, Inc.LTM Mar 2026$2.56M +32.8%—0.9%
Peer median (excluding ELMD) $2.56M+103.9%-40.9%1.0%

Competitors are the stored peer set for ELMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Net Income2.36M2.31M3.17M5.15M7.54M
Depreciation & Amortization610K628K613K841K1.17M
Deferred Income Tax(294K)(489K)(43K)(571K)(310K)
Stock-Based Compensation1.02M976K708K1.69M3.06M
Change in Working Capital(625K)(4.11M)(3.13M)1.96M(277K)
Accounts Receivables(3.58M)(3.91M)(3.28M)565K(1.64M)
Inventory971K(1.07M)(1.03M)459K175K
Accounts Payables214K2.17M420K(1.21M)1.65M
Other Working Capital1.77M(1.29M)763K2.14M(458K)
Other Non-Cash Items0000212K
Operating Cash Flow3.08M(686K)1.32M9.07M11.39M
Capital Expenditures(448K)(1.53M)(1.72M)(395K)(306K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(161K)0000
Investing Cash Flow(448K)(1.53M)(1.72M)(395K)(306K)
Debt Repayment00000
Common Stock Issued00000
Common Stock Repurchased(1.12M)(1.45M)(153K)(275K)(10M)
Dividends Paid00000
Other Financing Activities(95K)(77K)(227K)311K(1.88M)
Financing Cash Flow(1.22M)(1.53M)(380K)36K(11.88M)
Effect of Forex Changes00000
Net Change in Cash1.41M(3.74M)(781K)8.71M(793K)
Free Cash Flow2.63M(2.21M)(401K)8.67M11.09M

Electromed, Inc.

AMEX:ELMD

Intrinsic Alpha fair value

Locked

Current Price

$23.40

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.